Health disparities in COVID-19: immune and vascular changes are linked to disease severity and persist in a high-risk population in Riverside County, California
暂无分享,去创建一个
M. Kaul | Indira S. Harahap-Carrillo | Jiang Li | Michael T Ulrich | K. Pham | Kristina V. Bergersen | Xinru Qiu | Erica C Heinrich | M. Nair | Shyleen Frost | Adam Godzik | Patrick Merrill | Yuxin He | Sumaya Alaama | Keita Ichii
[1] V. Herrera,et al. Circulating neutrophil extracellular trap (NET)-forming ‘rogue’ neutrophil subset, immunotype [DEspR + CD11b +], mediate multi-organ failure in COVID-19—an observational study , 2023, Translational Medicine Communications.
[2] R. Root-Bernstein. From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children , 2023, International journal of molecular sciences.
[3] M. Jacobs,et al. Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of long COVID-19 , 2023, Journal of the National Medical Association.
[4] E. Topol,et al. Long COVID: major findings, mechanisms and recommendations , 2023, Nature Reviews Microbiology.
[5] Victor J. Avila-Quintero,et al. Association Between Patient Race and Ethnicity and Outcomes With COVID-19: A Retrospective Analysis From a Large Mid-Atlantic Health System , 2023, Journal of intensive care medicine.
[6] H. Niessen,et al. Atrial inflammation and microvascular thrombogenicity are increased in deceased COVID-19 patients , 2023, Cardiovascular Pathology.
[7] T. Aspelund,et al. Correlates of Coronavirus Disease 2019 Inpatient Mortality at a Southern California Community Hospital With a Predominantly Hispanic/Latino Adult Population , 2023, Open forum infectious diseases.
[8] C. Fisher,et al. Psychological Well-Being and Substance Use During the COVID-19 Pandemic: Ethnic/Racial Identity, Discrimination, and Vigilance , 2022, Journal of racial and ethnic health disparities.
[9] I. Kalomenidis,et al. Kinetics of Immune Subsets in COVID-19 Patients Treated with Corticosteroids , 2022, Viruses.
[10] M. Sato,et al. Severe COVID‐19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils , 2022, Scandinavian journal of immunology.
[11] L. Wooldridge,et al. Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19 , 2022, Life Science Alliance.
[12] M. Shkurnikov,et al. Association of HLA Class I Genotype with Mortality in Patients with Diabetes Mellitus and COVID-19 , 2022, Doklady Biochemistry and Biophysics.
[13] H. Hamadi,et al. COVID-19 Deaths and the Impact of Health Disparities, Hospital Characteristics, Community, Social Distancing, and Health System Competition. , 2022, Population health management.
[14] Rana Chakraborty,et al. The Elephant in the Waiting Room: An Urgent Call for Papers to Address the Public Health Crisis of Long COVID , 2022, Clinical nursing research.
[15] Young Hee Jung,et al. Preliminary Guidelines for the Clinical Evaluation and Management of Long COVID , 2022, Infection & chemotherapy.
[16] A. Godzik,et al. Resistin Concentration in Early Sepsis and All-Cause Mortality at a Safety-Net Hospital in Riverside County , 2022, Journal of inflammation research.
[17] R. Rabuñal Rey,et al. Assessment of Post-COVID Symptoms Using the C19-YRS Tool in a Cohort of Patients from the First Pandemic Wave in Northwestern Spain. , 2022, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.
[18] L. Cardell,et al. A prolonged innate systemic immune response in COVID-19 , 2022, Scientific Reports.
[19] W. Wierzba,et al. Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection , 2022, Frontiers in Immunology.
[20] S. Straudi,et al. Construct Validity and Responsiveness of the COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) in a Cohort of Italian Hospitalized COVID-19 Patients , 2022, International journal of environmental research and public health.
[21] Y. Tizabi,et al. COVID-19-Associated Coagulopathy: Role of Vitamins D and K. , 2022, Current Pharmaceutical Biotechnology.
[22] T. Mak,et al. Immune response in COVID-19: what is next? , 2022, Cell Death & Differentiation.
[23] A. Iwasaki,et al. Unexplained post-acute infection syndromes , 2022, Nature Medicine.
[24] Hui Li,et al. Identification of Neutrophil-Related Factor LCN2 for Predicting Severity of Patients With Influenza A Virus and SARS-CoV-2 Infection , 2022, Frontiers in Microbiology.
[25] S. Cavallero,et al. An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages , 2022, Theranostics.
[26] A. Brazma,et al. Single-Cell Analysis Reveals the Immune Characteristics of Myeloid Cells and Memory T Cells in Recovered COVID-19 Patients With Different Severities , 2022, Frontiers in Immunology.
[27] M. Sivan,et al. Post‐COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: A cross‐sectional evaluation from a community COVID rehabilitation service , 2021, Journal of medical virology.
[28] Diego C. B. Mariano,et al. VTR: A Web Tool for Identifying Analogous Contacts on Protein Structures and Their Complexes , 2021, Frontiers in Bioinformatics.
[29] H. Li,et al. Immune signatures underlying post-acute COVID-19 lung sequelae , 2021, Science Immunology.
[30] Matthew S. Miller,et al. Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections , 2021, medRxiv.
[31] S. Barry,et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection , 2021, BMC Medicine.
[32] Konrad U. Förstner,et al. 6th European Congress of Immunology, 1-4 September 2021, Virtual meeting. , 2021, European journal of immunology.
[33] N. Preston,et al. The COVID‐19 Yorkshire Rehabilitation Scale (C19‐YRS): Application and psychometric analysis in a post‐COVID‐19 syndrome cohort , 2021, medRxiv.
[34] S. Boyd,et al. Antibody and B cell responses to SARS-CoV-2 infection and vaccination , 2021, Cell Host & Microbe.
[35] S. Kent,et al. Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection , 2021, medRxiv.
[36] J. Lord,et al. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets , 2021, Frontiers in Immunology.
[37] J. Goeman,et al. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2 specific CD8 T cell responses following COVID-19 , 2021, medRxiv.
[38] M. Sivan,et al. The self-report version and digital format of the COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) for Long Covid or Post-COVID syndrome assessment and monitoring , 2021 .
[39] M. Katz,et al. Racial and Ethnic Health Disparities Related to COVID-19. , 2021, JAMA.
[40] R. Jafari,et al. Monocytes and macrophages in COVID-19: Friends and foes , 2021, Life Sciences.
[41] M. V. van Zelm,et al. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence , 2020, Science Immunology.
[42] Hong-juan Liu,et al. Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes , 2020, Journal of leukocyte biology.
[43] N. Babel,et al. Impaired Cytotoxic CD8+ T Cell Response in Elderly COVID-19 Patients , 2020, mBio.
[44] A. Nicholson,et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study , 2020, The Lancet Microbe.
[45] Manoj Sivan,et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation , 2020, Journal of medical virology.
[46] P. Groeneveld,et al. Health Disparities and the Coronavirus Disease 2019 (COVID-19) Pandemic in the USA , 2020, Journal of General Internal Medicine.
[47] V. Fuster,et al. Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19 , 2020, Journal of the American College of Cardiology.
[48] R. Assaly,et al. Elevated interleukin‐6 and severe COVID‐19: A meta‐analysis , 2020, Journal of medical virology.
[49] W. Tang,et al. Myeloperoxidase: a potential therapeutic target for coronary artery disease , 2020, Expert opinion on therapeutic targets.
[50] M. Netea,et al. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure , 2020, Cell Host & Microbe.
[51] Yutao Guo,et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up , 2020, Journal of the American College of Cardiology.
[52] R. Trimble. COVID-19 Dashboard , 2020 .
[53] Qiurong Ruan,et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.
[54] T. Davenport,et al. The potential for artificial intelligence in healthcare , 2019, Future Healthcare Journal.
[55] K. Borgwardt,et al. Machine Learning in Medicine , 2015, Mach. Learn. under Resour. Constraints Vol. 3.
[56] R. Foresti,et al. Human Sickle Cell Blood Modulates Endothelial Heme Oxygenase Activity: Effects on Vascular Adhesion and Reactivity , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[57] I. Tanganelli,et al. Oxidative stress, erythrocyte ageing and plasma non-protein-bound iron in diabetic patients , 2008, Free radical research.
[58] Shizuo Akira,et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron , 2004, Nature.
[59] A. Asada,et al. Elevated methemoglobin in patients with sepsis , 1998, Acta anaesthesiologica Scandinavica.
[60] A. Dauod,et al. Long COVID-19 prevalence among a sample of infected people in Erbil city. , 2022, Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique.
[61] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..